繁體
  • 简体中文
  • 繁體中文

熱門資訊> 正文

Organigram Global公布第四季度业绩

2025-12-16 19:03

  • Organigram Global press release (OGI): Q4 net loss increased to C$38.0 million, compared to a net loss of C$5.4 million in Q4 Fiscal 2024. The increase in net loss from the comparative period is primarily due non-cash changes in fair value of derivative liabilities, preferred shares and other financial assets.
  • Net revenue increased 79% to C$80.1 million, from C$44.7 million in the fourth quarter ended September 30, 2024 ("Q4 Fiscal 2024") primarily due to the contributions from the Motif acquisition, higher recreational cannabis sales and higher international sales.

風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。